Clinical trialObsRecruiting
Pancreatic Cancer and Diabetes Mellitus
Prospective Cohort Study on Endo-Exdo Secretory Function Alterations and All-round Outcomes After Pancreatic Cancer
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Recruiting
- Study type
- Observational
- Start
- 3 January 2025
- Expected end
- 1 September 2026
- Enrollment
- 150 participants
- Sites
- 1
- Primary outcomes
- Number of Participants Who developed glucose metabolic disorders(pre-diabetes and diabetes mellitus)
- Sponsor
- Other
- Results posted
- No
- Last update
- 1 July 2025
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The goal of this observational study is to learn about post-surgery of pancreatic cancer diabetes mellitus.The main questions it aims to answer are: 1. Are the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) after pancreatic cancer of different etiologies the same? 2. Are alterations in endocrine and exdocrine secretory function in patients with pancreatic surgery associated with all-round outcomes? All patients with pancreatic surgery have been given the standardized treatment for the condition. The reasearchers will summarize the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) during different surgical procedures to explore the association between alternations in endocrine and exdocrine secrectory function and all-round outcomes.
Detailed description public domain (ClinicalTrials.gov)
Investigators will prospectively collect data from patients with pancreatic cancer after surgery in participant centers.